Esculetin ameliorates cognitive impairments in D-galactose-induced Alzheimer's disease rats by inhibiting inflammation and oxidative stress
Esculetin ameliorates cognitive impairments in D-galactose-induced Alzheimer's disease rats by inhibiting inflammation and oxidative stress. Pharmacognosy Magazine [Internet]. 2022;18(79):540-547. http://www.phcog.com/text.asp?2022/18/79/540/356403
.